These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 453449)

  • 21. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z; Zhang R; Zhou D; Chen J
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. I. Overview of the study.
    Schreuder PA
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):149-58. PubMed ID: 9728447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epidemiology of leprosy in Guadeloupe from 1970 to 1984].
    Cartel JL; Gallais JJ; Naudillon Y; Rémy JG; Grosset JH
    Acta Leprol; 1986; 4(2):161-73. PubMed ID: 3551448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
    Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS
    Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transmission of leprosy within households.
    Rao PS; Karat AB; Kaliaperumal VG; Karat S
    Int J Lepr Other Mycobact Dis; 1975; 43(1):45-54. PubMed ID: 1171831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does MDT arrest transmission of leprosy to household contacts?
    Vijayakumaran P; Jesudasan K; Mozhi NM; Samuel JD
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):125-30. PubMed ID: 9728444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bacteriologic study in patients with multibacillary leprosy treated with rifampicin and acedapsone].
    Olivares Sabournin R; González Segredo AB
    Rev Cubana Med Trop; 1989; 41(2):307-12. PubMed ID: 2486227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):161-72. PubMed ID: 1522358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of sulphone therapy on lepromin reaction.
    Ramu G; Sengupta U; Desikan KV
    Lepr Rev; 1980 Sep; 51(3):207-14. PubMed ID: 7442412
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term follow-up of families in an endemic area.
    Ranade MG; Joshi GY
    Indian J Lepr; 1995; 67(4):411-25. PubMed ID: 8849918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repository acedapsone in leprosy chemoprophylaxis and treatment.
    Sloan NR; Worth RM; Jano B; Fasal P; Shepard CC
    Lancet; 1971 Sep; 2(7723):525-6. PubMed ID: 4105668
    [No Abstract]   [Full Text] [Related]  

  • 33. A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: design, methodology and recruitment findings of COLEP.
    Moet FJ; Oskam L; Faber R; Pahan D; Richardus JH
    Lepr Rev; 2004 Dec; 75(4):376-88. PubMed ID: 15682975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An epidemiological analysis of leprosy from 1951-1996 in Sichuan.
    Wu XS; Ning Y; Shi L; Jin Z; Yang JW
    Indian J Lepr; 2000; 72(2):215-26. PubMed ID: 11008661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years.
    Norman G; Joseph G; Richard J
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):1-7. PubMed ID: 15217321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acedapsone in leprosy treatment: trial in 68 active cases in Micronesia.
    Sloan NR; Worth RM; Jano B; Fasal P; Shepard CC
    Int J Lepr Other Mycobact Dis; 1972; 40(1):48-52. PubMed ID: 4672994
    [No Abstract]   [Full Text] [Related]  

  • 37. Patient contact is the major determinant in incident leprosy: implications for future control.
    van Beers SM; Hatta M; Klatser PR
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):119-28. PubMed ID: 10472363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case finding survey for leprosy in Botswana.
    Kumaresan JA; Khulumani P; Maganu ET
    East Afr Med J; 1993 Oct; 70(10):635-8. PubMed ID: 8187660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Leprosy in Lome, Togo: retrospective study of 383 cases].
    Saka B; Kombate K; Mouhari-Toure A; Amegan-Aho KH; Tchangai-Walla K; Pitche P
    Med Trop (Mars); 2008 Oct; 68(5):496-8. PubMed ID: 19068982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.